Table 1.
The effect of ischaemia/reperfusion (IR) on flow-mediated dilation (FMD) in the seven groups
Before IR Resting | FMD, diameter change | After IR Resting | FMD, diameter change | |
---|---|---|---|---|
Protocol 1 | ||||
Vitamin C alone | 2.60 ± 0.1 | 0.20 ± 0.08 | 2.65 ± 0.1 | 0.03 ± 0.03*‡ |
No therapy | 2.38 ± 0.1 | 0.18 ± 0.03 | 2.41 ± 0.1 | 0.03 ± 0.02*‡ |
GTN + placebo | 2.55 ± 0.1 | 0.22 ± 0.02 | 2.52 ± 0.1 | 0.13 ± 0.03†‡ |
GTN + vitamin C | 2.48 ± 0.1 | 0.18 ± 0.02 | 2.57 ± 0.1 | 0.05 ± 0.02*‡ |
Protocol 2 | ||||
GTN alone | 2.65 ± 0.1 | 0.19 ± 0.03 | 2.68 ± 0.1 | 0.15 ± 0.03§ |
GTN + ciclosporin | 2.48 ± 0.1 | 0.15 ± 0.01 | 2.49 ± 0.1 | 0.04 ± 0.02*§ |
Ciclosporin | 2.33 ± 0.1 | 0.17 ± 0.02 | 2.42 ± 0.1 | 0.08 ± 0.02*§ |
Radial artery diameter data (in mm). ‘Baseline’ data refer to radial artery diameter before wrist cuff occlusion. ‘FMD, diameter change’ data refer to maximal dilation after wrist cuff release.
P < 0.01 compared with before IR
P < 0.05 compared with before IR, within-group
P < 0.01 anova
P < 0.05 anova.